StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Insys Therapeutics (INSY) Releases Statement Addressing New York Attorney General’s Complaint
February 2, 2018 5:47 AM
INSYS Therapeutics, Inc. (NASDAQ: INSY) today released the following statement in response to a complaint filed by the New York ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Litigation
Management Comments
Next Articles
INSYS Therapeutics Addresses New York Attorney General’s Complaint
February 1, 2018 11:00 PM
NY AG Sues Insys Therapeutics (INSY) Over Promotion of Prescription Opioid Subsys - Bloomberg
February 1, 2018 2:39 PM
Insys Therapeutics (INSY) Names Vaseem Mahboob to Board
February 1, 2018 9:07 AM